Navigation Links
Success Factors and Failure Points for Oncology New Product Launches
Date:7/22/2011

CHAPEL HILL, N.C., July 22, 2011 /PRNewswire/ -- The oncology therapeutic area continues to be an active sector for new pharmaceutical product investment and launches as next generation oncology therapies find success in a competitive marketplace. With more new targeted oncology products finding success, organizations in the oncology therapeutic area are facing a crowded marketplace that is pushing them to rethink the factors that play the biggest role in the current launch environment.

In a new wide-ranging research project that explores the pivotal success factors and failure points facing new oncology product launches, Best Practices, LLC established a critical core set of factors that can make or break a market entry for cancer products as well as other types of therapies. As more products target the same disease mechanism, the need for differentiation has become vital and, likewise, the price of oncology products has made it critical to present a compelling value argument to payers.

The benchmarking study presents a framework for launch success:  the ability to differentiate, a defined target patient population, investment in launch activities, engagement of thought leaders, education of key stakeholders, demonstration of value, utilization of new technologies and avoidance of launch pitfalls. The report, Success Factors and Failure Points in Oncology Product Launches, examines each of these key launch issues and offers launch leaders two perspectives: an oncology segment and a total benchmark class segment that includes other therapeutic areas.

In addition to delivering qualitative and quantitative insights on each aspect of this launch framework, the 182-page report presents launch leaders' perspectives on the current and future risk levels for an array of pitfall factors that can affect a new product launch.

To download a complimentary study excerpt, go to: http://www3.best-in-class.com/rr1096.htm.

Best Practices, LLC used both field surveys and interviews to complete this study. In all, 44 managers and executives at 38 leading bio-pharma companies participated in the survey.  In-depth interviews were conducted with leaders from six organizations who have decades of experience with pharmaceutical launches.

Topics covered in this study include:

  • Winning on Differentiated Product Positioning
  • Winning a Physician's Initial Trial of a New Product
  • Articulating Benefits that Shape Positive Market Perception
  • New Product Pricing Strategy
  • Thought Leader Engagement
  • Early Physician Education
  • Payer Education
  • Patient Education and Advocacy
  • Preparing Market Constituents
  • Access Insights & Success Factors
  • Winning Hospital Formulary Access
  • Resource Allocation for Key Stakeholders
  • Investment Requirements, Resource Allocation & Timing
  • Internal Launch Readiness
  • New Technologies for Informing Patients and Physicians
  • Pitfalls and Stumbling Blocks
  • Demonstrating Efficacy
  • Rating Different Safety Dimensions

ABOUT BEST PRACTICES, LLC

Best Practices, LLC serves 48 of the world's 50 top companies in the pharmaceutical industry for more than 17 years.  For more information about the company, go to www.best-in-class.com.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Early Stage Commercialization: Keys to Successful New Product Launch
2. Diplomat Specialty Pharmacy 2011 Patient Satisfaction Survey Results Affirm Success of Companys Patient Focused Model
3. Chinese Biopharmaceutical Association Successfully Holds 16th Annual Conference
4. Unilife Successfully Completes Industrialization of Unifill Syringe
5. Medical Messenger Partners With ComputerAssistant.com to Provide Key Elements of Meaningful Use Success
6. Jubilant and AstraZeneca Announce Successful Delivery of Early Milestones in Drug Discovery
7. Particle Sciences Develops Proprietary Nasal Delivery Formulation Used in Neurelis Recently Announced Successful Phase I Pharmacokinetic Study of NRL-01 (intranasal diazepam)
8. Altair Semiconductor Successfully Demonstrates its LTE Chipset Speeds and Service for China Mobile Executives
9. Accuray Successfully Completes Acquisition of TomoTherapy
10. Educating Key Stakeholders to Support a Successful Pharmaceutical Product Launch
11. Crux Successfully Completes Funding for Advanced Filter for PE Prevention
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... -- The Rebound mobile app is poised to become a ... of prescription drug addiction. The app empowers users to develop ... down their dosage in a safe, controlled manner while maximizing ... first 100,000 people to sign up will enjoy 3 months ... ...
(Date:9/25/2017)... 25, 2017   Montrium , an industry ... today—from the IQPC Trial Master Files & Inspection ... that EastHORN Clinical Services has selected eTMF ... TMF management. EastHORN, a leading European contract research ... increase transparency to enable greater collaboration with sponsors, ...
(Date:9/19/2017)... Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses ... today:   ... Jim ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and business ...
Breaking Medicine Technology:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... PurhealthRX ... CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will ... and providing a CBD form that can be easily incorporated into liquid products, while ...
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance that covers care ... have a waiver for care if the client has a cognitive impairment diagnosis. ... for care, is often waived, so the benefits from their insurance start immediately,” said ...
(Date:10/13/2017)... Texas (PRWEB) , ... October 13, 2017 , ... Yisrayl ... this week that explains one of the most popular and least understood books in ... like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and ... of published author, William Nowers. Captain Nowers and his wife, Millie, have six ... years in the Navy. Following his career as a naval aviator and carrier ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed a ... and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been ... standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, ...
Breaking Medicine News(10 mins):